V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005246 | 330002505 | 0 | null | Curative (C) | 2017-08-07 | 2017-08-07 | AML Int Guide ADE 10+3+5 (1) | N | null | 330022399 | AML17 TRIAL |
| 330005248 | 330002507 | 1.6 | 79.9 | Adjuvant (A) | 2013-09-13 | 2013-11-23 | VIDE | N | N | 330022429 | BEP |
| 330005249 | 330002508 | 1.61 | 65.5 | Neo-adjuvant (N) | 2015-03-04 | 2015-03-04 | CNS LGG 2004 03 vinc weekly+ carbo | null | null | 330022433 | FEC |
| 330005250 | 330002508 | 1.83 | 75.9 | Palliative (P) | 2015-01-06 | 2015-01-14 | Doxorubicin + Ifosfamide | 2 | N | 330022433 | DOCETAXEL + GEMCITABINE |
| 330005251 | 330002509 | 1.62 | 56.2 | Curative (C) | 2016-08-09 | 2016-08-22 | CHOP | N | N | 330022450 | ECX |
| 330005252 | 330007382 | 1.65 | null | Palliative (P) | 2017-05-13 | 2017-05-20 | ETOPOSIDE | N | N | 330022462 | CHLORAMBUCIL |
| 330005253 | 330002510 | null | 58.2 | Palliative (P) | 2014-09-29 | 2014-10-02 | CISPLATIN + FLUOROURACIL + GEMCITABINE | 2 | N | 330022463 | CAPECITABINE + OXALIPLATIN |
| 330005254 | 330002511 | 1.76 | 74 | Curative (C) | null | 2013-04-10 | Cetuximab +Cisplatin + FU (Cycle 1) | null | null | 330022484 | ECX |
| 330005255 | 330002511 | 1.33 | 0 | Curative (C) | 2017-10-11 | 2017-10-18 | Etoposide oral | N | N | 330022484 | BORTEZOMIB + RITUXIMAB |
| 330005256 | 330002511 | null | 71 | Curative (C) | 2015-09-25 | 2015-09-28 | FLAG + Idarubicin | 02 | null | 330022484 | VINBLASTINE |
| 330005257 | 330002512 | 1.67 | 60.2 | Palliative (P) | 2017-06-06 | 2017-06-21 | MITOTANE | N | N | 330022491 | MITOTANE |
| 330005258 | 330002513 | null | 76 | Adjuvant (A) | 2016-11-06 | 2016-12-14 | Doxorubicin + Olaratumab | N | N | 330022493 | CARBOPLATIN + RT |
| 330005259 | 330002514 | 1.53 | 78.5 | Palliative (P) | 2017-11-16 | 2017-11-16 | PEMBROLIZUMAB | 02 | N | 330022508 | VIDE |
| 330005260 | 330002515 | 1.82 | null | Palliative (P) | 2016-01-24 | 2016-01-24 | Chlorambucil | 02 | null | 330022510 | LIPOSOMAL DAUNORUBICIN |
| 330005261 | 330002515 | 1.87 | 90.6 | Curative (C) | 2015-08-08 | 2015-08-09 | EDP + MITOTANE | 02 | null | 330022510 | CAPECITABINE + CARBOPLATIN |
| 330005262 | 330002516 | 0 | 76.9 | Neo-adjuvant (N) | 2015-12-17 | 2016-01-13 | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | N | 330022524 | CLADRIBINE |
| 330005263 | 330002517 | 1.77 | 17.4 | null | 2014-05-10 | 2014-05-10 | Azacitidine | N | N | 330022530 | DOXORUBICIN + IFOSFAMIDE |
| 330005264 | 330002517 | 1.65 | 76.9 | Palliative (P) | null | 2014-04-15 | ECX | Y | Y | 330022530 | CARBOPLATIN + CETUXIMAB + FU |
| 330005265 | 330002518 | 1.74 | 70.4 | Disease modification (D) | 2013-11-14 | 2013-11-27 | CYTARABINE + MITOXANTRONE | 2 | N | 330022534 | ABIRATERONE |
| 330005266 | 330002519 | null | 100.2 | Adjuvant (A) | null | 2018-03-06 | FLAG + Idarubicin | null | null | 330022556 | VINCRISTINE |
| 330005267 | 330007386 | 1.79 | 102.1 | null | 2013-11-12 | 2013-11-14 | Azacitidine | null | null | 330022566 | VIDE |
| 330005268 | 330010009 | 1.69 | 49.4 | Palliative (P) | 2018-06-29 | 2018-06-30 | CTD Attenuated (Thalidomide 50mg) | N | N | 330022588 | HYDROXYCARBAMIDE |
| 330005269 | 330002520 | 1.58 | 46.8 | Curative (C) | 2014-11-01 | 2014-11-07 | Epirubicin | N | N | 330022589 | CAPECITABINE + VINORELBINE |
| 330005270 | 330002520 | null | 67.9 | Curative (C) | 2016-10-22 | 2016-11-04 | METHOTREXATE | N | N | 330022589 | CISPLATIN + DOCETAXEL |
| 330005272 | 330002522 | 1.77 | null | null | 2015-05-26 | 2016-09-19 | AML 19 TRIAL | 02 | Y | 330022612 | BORTEZOMIB |
| 330005273 | 330002523 | 1.7 | 0 | Not known (9) | 2016-12-23 | 2016-12-23 | Hydroxycarbamide | 02 | null | 330022618 | SUNITINIB |
| 330005274 | 330002524 | 1.53 | 76.1 | Palliative (P) | 2017-03-19 | 2017-03-30 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 330022622 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 330005275 | 330002524 | null | null | Neo-adjuvant (N) | 2013-09-11 | 2013-09-11 | GC Int Guide Excranial GermCell JEB | N | N | 330022622 | CAPECITABINE + CARBOPLATIN |
| 330005276 | 330002524 | 1.75 | 101 | Palliative (P) | 2017-07-25 | 2017-08-20 | Cladribine (subcut) 5 days | 02 | N | 330022622 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 330005279 | 330002526 | 1.59 | 96 | Palliative (P) | 2013-09-08 | 2013-09-14 | RAVVA TRIAL | 02 | N | 330022662 | VIDE |
| 330005280 | 330002527 | 1.76 | 74.6 | Palliative (P) | null | 2014-06-11 | CNS HGG Temozolomide +XRT | Y | N | 330022697 | FLAG + IDARUBICIN |
| 330005281 | 330002528 | 1.83 | 59 | Palliative (P) | 2018-08-02 | 2018-08-02 | BEP 5 Day | 02 | N | 330022701 | POMB/ACE |
| 330005282 | 330002529 | 0 | 59.9 | Palliative (P) | 2014-02-22 | 2014-03-03 | Docetaxel | N | N | 330022714 | CVD |
| 330005283 | 330002529 | 1.75 | 76.2 | Curative (C) | null | 2015-04-07 | Capecitabine (14 days)+Carboplatin | N | N | 330022714 | CISPLATIN + DOX + ETOPOSIDE |
| 330005284 | 330002529 | null | 55 | null | 2013-11-01 | 2013-11-06 | R Chlorambucil | N | N | 330022714 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 330005285 | 330002530 | 1.53 | 80.4 | Palliative (P) | 2017-06-22 | 2017-06-27 | VAI (Ifos 3g/m2) | N | N | 330022730 | CARBOPLATIN + VINORELBINE |
| 330005286 | 330002530 | 1.83 | 94.2 | Neo-adjuvant (N) | 2015-05-31 | 2015-06-14 | Doxorubicin + Olaratumab | N | N | 330022730 | BENDAMUSTINE |
| 330005287 | 330002531 | 0 | 0 | Not known (9) | 2017-10-14 | 2017-10-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | 330022740 | TEMOZOLOMIDE |
| 330005288 | 330002532 | null | null | null | null | 2017-08-21 | Cisplatin + Fluorouracil + RT 5day | 02 | null | 330022755 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330005289 | 330002532 | 0 | 87 | Curative (C) | 2017-08-13 | 2017-08-14 | AML17 TRIAL | N | N | 330022755 | FCR |
| 330005290 | 330002532 | 1.76 | 65.5 | Disease modification (D) | 2014-09-27 | 2014-09-27 | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 02 | N | 330022755 | CARBOPLATIN + VINORELBINE |
| 330005291 | 330002533 | 1.68 | 80.1 | Palliative (P) | null | 2014-04-25 | Cyclophosphamide + Vincristine | N | N | 330022798 | CARBOPLATIN + VINCRISTINE |
| 330005292 | 330002533 | 1.79 | 8.4 | Palliative (P) | 2016-05-07 | 2016-05-07 | Doxorubicin + Ifosfamide | 2 | N | 330022798 | HYDROXYCARBAMIDE |
| 330005293 | 330002534 | null | null | Palliative (P) | 2017-01-29 | 2017-12-30 | Cytarabine Low Dose | N | N | 330022807 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 330005294 | 330002535 | 1.59 | 67 | Palliative (P) | 2014-11-28 | 2014-12-01 | DACTINOMYCIN | 02 | N | 330022810 | PAZOPANIB |
| 330005295 | 330002536 | 1.75 | 0 | Curative (C) | 2018-01-13 | 2018-01-17 | Mitotane 2g | N | N | 330022813 | CARBOPLATIN + PEMETREXED |
| 330005296 | 330002536 | 1.57 | 50 | Curative (C) | 2015-05-30 | 2015-06-14 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 330022813 | CHOP |
| 330005297 | 330010013 | -1 | null | Curative (C) | 2015-10-02 | 2015-10-28 | Cisplatin + Docetaxel | N | N | 330022832 | BLEOMYCIN |
| 330005298 | 330002537 | 1.82 | 82.2 | Disease modification (D) | 2014-07-06 | 2014-07-06 | Doxorubicin + Ifosfamide | Y | N | 330022859 | UKALL2011 |
| 330005299 | 330002538 | 1.7 | 136 | null | 2013-05-02 | 2013-05-14 | BEP 5 Day | 02 | N | 330022863 | BORTEZOMIB |